Demonstration of upregulated H2 relaxin mRNA expression during neuroendocrine differentiation of LNCaP prostate cancer cells and production of biologically active mammalian recombinant 6 histidine-tagged H2 relaxin

Annals of the New York Academy of Sciences

Volumn 1041, Issue , 2005, Pages 320-327

  Figueiredo, Kevin A ^a,b   Palmer, Jodie B ^b   Mui, Alice L ^a   Nelson, Colleen C ^a,b   Cox, Michael E ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

LNCaP; Neuroendocrine differentiation; Prostate cancer; Relaxin; THP 1

Indexed keywords

ADRENALIN; COMPLEMENTARY DNA; CYCLIC AMP; HISTIDINE; HUMAN RELAXIN 2; INTERLEUKIN 6; ISOBUTYLMETHYLXANTHINE; RELAXIN; RNA; UNCLASSIFIED DRUG;

CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL TYPE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NEUROENDOCRINE SYSTEM; PROSTATE CANCER;

MAMMALIA;

EID: 23644432401     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1282.051     Document Type: Conference Paper

References (19)

1. Canadian Cancer Society. 2004. (www.cancer.ca).
2. SILVERTOWN, J.D., A.J. SUMMERLEE & T. KLONISCH. 2003. Relaxin-like peptides in cancer. Int. J. Cancer 107: 513-519.
3. BANI, D. 1997. Relaxin: a pleiotropic hormone. Gen. Pharmacol. 28: 13-22.
4. IVELL, R. & A. EINSPANIER. 2002. Relaxin peptides are new global players. Trends Endocrinol. Metab. 13: 343-348.
5. BATHGATE, R.A., C.S. SAMUEL, T.C. BURAZIN, et al. 2003. Relaxin: new peptides, receptors and novel actions. Trends Endocrinol. Metab. 14: 207-213.
6. BINDER, C., L. BINDER, G. LUDER, et al. 2000. High serum concentrations of relaxin correlate with dissemination of breast cancer. In G. Tregear, R. Ivell, R. Bathgate, et al., Eds. :429-435. Proceedings from the Third International Congress on Relaxin and Related Peptides. Kluwer Academic Publisher. Dordrecht.
7. GUNNERSEN, J.M., P.J. ROCHE, G.W. TREGEAR, et al. 1995. Characterization of human relaxin gene regulation in the relaxin-expressing human prostate adenocarcinoma cell line LNCaP.FGC. J. Mol. Endocrinol. 15: 153-166.
8. BANI SACCHI, T., D. BANI, M.L. BRANDI, et al. 1994. Relaxin influences growth, differentiation and cell-cell adhesion of human breast-cancer cells in culture. Int. J. Cancer 57: 129-134.
9. BINDER, C., T. HAGEMANN, B. HUSEN, et al. 2002. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Mol. Hum. Reprod. 8: 789-796.
10. DEEBLE, P.D., J.D. MURPHY, S.J. PARSONS, et al. 2001. Interleukin-6 and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. Mol. Cell Biol. 21: 8471-8482.
11. GUNNERSEN, J.M., P. FU, P.J. ROCHE, et al. 1996. Expression of human relaxin genes: characterization of a novel alternatively-spliced human relaxin mRNA species. Mol. Cell Endocrinol. 118: 85-94.
12. HSU, S.Y., K. NAKABAYASHI, S. NISHI, et al. 2002. Activation of orphan receptors by the hormone relaxin. Science 295: 671-674.
13. DI SANT'AGNESE, P. & A. COCKETT. 1996. Neuroendocrine differentiation in prostatic malignancy. Cancer 78: 357-361.
14. BONKHOFF, H., N. WERNERT, G. DHOM, et al. 1991. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate 19: 91-98.
15. BONKHOFF, H. 1998. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status. Prostate Suppl. 8: 18-22.
16. BULLESBACH, E. & C. SCHWABE. 2000. The relaxin receptor-binding site geometry suggests a novel gripping mode of interaction. J. Biol. Chem. 275: 35276-35280.
17. BALKWILL, F. 2004. Cancer and the chemokine network. Nat. Rev. Cancer 4: 540-550.
18. PARSELL, D.A., J.Y. MAK, E.P. AMENTO, et al. 1996. Relaxin binds to and elicits a response from cells of the human monocytic cell line, THP-1. J. Biol. Chem. 271: 27936-27941.
19. BARTSCH, O., B. BARTLICK & R. IVELL. 2001. Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity. Mol. Hum. Reprod. 7: 799-809.